Skip to content
healthcare.dev
Get a free key

Anacin

NDC 63736-200, Asprin and Caffeine, tablet, from Insight Pharmaceuticals LLC.

Product NDC
63736-200
Status
Listed
Labeler
Insight Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63736-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN400 mg/1
  • CAFFEINE32 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
63736-200-90637360200901 BOTTLE in 1 BOX (63736-200-90) / 100 TABLET in 1 BOTTLE
63736-200-93637360200931 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63736-200 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63736-200 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63736-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.